Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
225,970,109
-
Total 13F shares
-
234,666,772
-
Share change
-
-3,833,961
-
Total reported value
-
$44,173,109,626
-
Put/Call ratio
-
123%
-
Price per share
-
$188.13
-
Number of holders
-
842
-
Value change
-
-$691,902,449
-
Number of buys
-
374
-
Number of sells
-
368
Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q2 2017
As of 30 Jun 2017,
Elevance Health, Inc. - Common Stock (ELV) was held by
842 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
234,666,772 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, FMR LLC, BARROW HANLEY MEWHINNEY & STRAUSS LLC, BAILLIE GIFFORD & CO, WELLINGTON MANAGEMENT GROUP LLP, Orbis Allan Gray Ltd, and Invesco Ltd..
This page lists
843
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.